Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Sequus seeks FDA approval for new indication of Amphotec

March 14, 1997

Clinical trial results for Neuprex in hepatectomy and meningococcemia

March 13, 1997

Long-acting injectable antifungal enters phase II trials

March 13, 1997

Antiherpesvirus agent from Roche

March 13, 1997

Antifungal agents from Nihon Nohyaku

March 13, 1997

GS-4104 enters human testing

March 12, 1997

SKB's Vectavir introduced in Germany

March 12, 1997

Genome Therapeutics and Versicor collaborate on new antibacterial compounds

March 12, 1997

New antibacterial agents from Daiichi

March 12, 1997

Antibacterial agent isolated by Sanwa Kagaku

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...